glp 1 and kidney cancer Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic disease through dampening the receptor for advanced glycation end products–induced inflammation Frontiers | GLP-1 Receptor Agonists

At the same time, official labeling and many clinical recommendations remain cautious because breastfeeding safety data is still limited, and because these medications may affect appetite, nutrition, hydration, and possibly milk supply

Circulation 136:849870 Honigberg MC, Chang LS, McGuire DK, Plutzky J, Aroda VR, Vaduganathan M (2020) Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Review

The medication your doctor recommends will depend on its effectiveness, safety, and benefits for other health conditions

89,90 Although all causes and contributors of obesity are not within an individuals control, structured lifestyle modification programs can be effective and feasible to help achieve a 5-10% weight reduction and maintain a healthy body weight for many people